Related Experiment Video
Updated: Jul 31, 2025

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
Factor VII Deficiency and Second Trimester Abortion: A Case Report
Katie P Nguyen1, Tamara Lynne B Aqui2, Honey Milestone3
1Family Medicine, Riverside Community Hospital, Riverside, USA.
Managing factor VII deficiency (F7D) in pregnancy is challenging due to its rarity. This case demonstrates successful management of a pregnant patient with F7D undergoing medical abortion and surgery.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Orthopedic Surgery
Background:
- Factor VII deficiency (F7D) is a rare bleeding disorder with a prevalence of 1 in 500,000.
- The management of bleeding disorders, particularly F7D, during pregnancy is not well-established, posing significant clinical challenges.
More Related Videos
08:13Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
09:51Model Surgical Training: Skills Acquisition in Fetoscopic Laser Photocoagulation of Monochorionic Diamniotic Twin Placenta Using Realistic Simulators
Published on: March 21, 2018
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Teratogenicity
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...